Literature DB >> 24163408

Nod1 and Nod2 enhance TLR-mediated invariant NKT cell activation during bacterial infection.

Thirumahal Selvanantham1, Nichole K Escalante, Mayra Cruz Tleugabulova, Stephanie Fiévé, Stephen E Girardin, Dana J Philpott, Thierry Mallevaey.   

Abstract

Invariant NKT (iNKT) cells act at the crossroad between innate and adaptive immunity and are important players in the defense against microbial pathogens. iNKT cells can detect pathogens that trigger innate receptors (e.g., TLRs, Rig-I, Dectin-1) within APCs, with the consequential induction of CD1d-mediated Ag presentation and release of proinflammatory cytokines. We show that the cytosolic peptidoglycan-sensing receptors Nod1 and Nod2 are necessary for optimal IFN-γ production by iNKT cells, as well as NK cells. In the absence of Nod1 and Nod2, iNKT cells had a blunted IFN-γ response following infection by Salmonella enterica serovar Typhimurium and Listeria monocytogenes. For Gram-negative bacteria, we reveal a synergy between Nod1/2 and TLR4 in dendritic cells that potentiates IL-12 production and, ultimately, activates iNKT cells. These findings suggest that multiple innate pathways can cooperate to regulate iNKT cell activation during bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24163408     DOI: 10.4049/jimmunol.1301412

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

Review 2.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

Review 3.  The dialogue between unconventional T cells and the microbiota.

Authors:  Qiaochu Lin; Meggie Kuypers; Dana J Philpott; Thierry Mallevaey
Journal:  Mucosal Immunol       Date:  2020-07-23       Impact factor: 7.313

Review 4.  CAR-armed cell therapy for gliomas.

Authors:  You Zhai; Guanzhang Li; Tao Jiang; Wei Zhang
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

5.  Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses.

Authors:  Jeeyoon Jennifer Ahn; Thirumahal Selvanantham; Monan Angela Zhang; Thierry Mallevaey; Shannon E Dunn
Journal:  J Vis Exp       Date:  2016-11-16       Impact factor: 1.355

6.  Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium colitis.

Authors:  Alanna M Spees; Dawn D Kingsbury; Tamding Wangdi; Mariana N Xavier; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

Review 7.  The regulatory role of invariant NKT cells in tumor immunity.

Authors:  Rosanna M McEwen-Smith; Mariolina Salio; Vincenzo Cerundolo
Journal:  Cancer Immunol Res       Date:  2015-05       Impact factor: 11.151

8.  Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B Streptococcus serotypes III and V.

Authors:  Paul Lemire; David Roy; Nahuel Fittipaldi; Masatoshi Okura; Daisuke Takamatsu; Eugenia Bergman; Mariela Segura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

9.  Salmonella enterica serovar Typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice.

Authors:  Anne-Kathrin Claes; Natalie Steck; Dorothee Schultz; Ulrich Zähringer; Simone Lipinski; Philip Rosenstiel; Kaoru Geddes; Dana J Philpott; Holger Heine; Guntram A Grassl
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

10.  Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation.

Authors:  Rocío Navarro; Pablo Delgado-Wicke; Natalia Nuñez-Prado; Marta Compte; Ana Blanco-Toribio; Gabriel Nuñez; Luis Álvarez-Vallina; Laura Sanz
Journal:  J Cell Mol Med       Date:  2016-02-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.